Empagliflozin Tablets Market, Global Outlook and Forecast 2024-2031

This report contains market size and forecasts of Empagliflozin Tablets in global, including the following market information:
Global Empagliflozin Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Empagliflozin Tablets Market Sales, 2017-2022, 2023-2028, (Ton)
Global top five Empagliflozin Tablets companies in 2021 (%)
The global Empagliflozin Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Empagliflozin Tablets include Boehringer Ingelheim, Kelun, CTTQ, Wangbang, Jiangsu Aosaikang Pharmaceutical, HANSOH, MSN Labs and Lupin Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Empagliflozin Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Empagliflozin Tablets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Empagliflozin Tablets Market Segment Percentages, by Type, 2021 (%)
10mg
25mg
Global Empagliflozin Tablets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Empagliflozin Tablets Market Segment Percentages, by Application, 2021 (%)
Hospitals
Drug Stores
Others
Global Empagliflozin Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Empagliflozin Tablets Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Empagliflozin Tablets revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Empagliflozin Tablets revenues share in global market, 2021 (%)
Key companies Empagliflozin Tablets sales in global market, 2017-2022 (Estimated), (Ton)
Key companies Empagliflozin Tablets sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Kelun
CTTQ
Wangbang
Jiangsu Aosaikang Pharmaceutical
HANSOH
MSN Labs
Lupin Limited